prescription medications, as federal officials prepare to revisit a proposal that would align certain drug prices with the lower rates found in other developed countries.
According to individuals familiar with the matter, the proposal—known as a “most favored nation” pricing policy—could be advanced through an executive order in the coming days. The initiative would apply to a selection of
drugs covered under Medicare and aims to bring U.S. prices closer to those paid by other nations, where prescription medications often cost significantly less.
The plan, still under internal review, is being shaped by senior administration officials and healthcare policy advisers. If finalized, it would represent a major shift in how the federal government negotiates—or benchmarks—the cost of medications purchased for millions of Americans.
